The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Anders Jack since 2020.
This trader's CIK number is 1800668.
At the time of last reporting, Anders Jack was the Chief Financial Officer of Revolution Medicines, Inc.. (stock ticker symbol RVMD).
Also see all insider trading activities at Revolution Medicines, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RVMD | 0 | $0 | 14,034 | $560,192 | 10,000 | $74,553 |
| 2024 | RVMD | 0 | $0 | 26,140 | $1,161,856 | 20,000 | $53,600 |
| 2023 | RVMD | 0 | $0 | 25,116 | $837,327 | 44,524 | $136,613 |
| 2022 | RVMD | 0 | $0 | 1,014 | $18,715 | 0 | $0 |
| 2021 | RVMD | 0 | $0 | 496 | $14,591 | 0 | $0 |
| 2020 | RVMD | 0 | $0 | 20,000 | $840,000 | 20,000 | $53,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-03 | RVMD | Sale | 5,238 | 40.17 | 210,431 |
| 2025-09-02 | RVMD | Option Ex | 4,762 | 3.71 | 17,643 |
| 2025-09-03 | RVMD | Option Ex | 5,238 | 10.87 | 56,910 |
| 2025-09-02 | RVMD | Sale | 4,762 | 40.02 | 190,560 |
| 2025-06-16 | RVMD | Sale | 2,170 | 39.83 | 86,431 |
| 2025-03-17 | RVMD | Sale | 1,864 | 39.04 | 72,770 |
| 2024-12-16 | RVMD | Sale | 2,635 | 45.40 | 119,639 |
| 2024-10-11 | RVMD | Sale | 10,000 | 50.30 | 502,980 |
| 2024-10-11 | RVMD | Option Ex | 10,000 | 2.68 | 26,800 |
| 2024-09-16 | RVMD | Sale | 2,244 | 44.19 | 99,151 |
| 2024-05-03 | RVMD | Sale | 10,000 | 40.03 | 400,260 |
| 2024-05-03 | RVMD | Option Ex | 10,000 | 2.68 | 26,800 |
| 2024-03-18 | RVMD | Sale | 1,261 | 31.58 | 39,826 |
| 2023-12-18 | RVMD | Sale | 1,775 | 25.90 | 45,976 |
| 2023-10-23 | RVMD | Option Ex | 24,524 | 3.38 | 83,013 |
| 2023-09-18 | RVMD | Sale | 1,427 | 31.31 | 44,680 |
| 2023-09-01 | RVMD | Option Ex | 20,000 | 2.68 | 53,600 |
| 2023-09-01 | RVMD | Sale | 20,000 | 35.05 | 701,100 |
| 2023-06-20 | RVMD | Sale | 1,249 | 24.89 | 31,088 |
| 2023-03-17 | RVMD | Sale | 665 | 21.78 | 14,483 |
| 2022-09-19 | RVMD | Sale | 449 | 19.04 | 8,550 |
| 2022-06-17 | RVMD | Sale | 406 | 17.75 | 7,206 |
| 2022-03-17 | RVMD | Sale | 159 | 18.62 | 2,959 |
| 2021-12-17 | RVMD | Sale | 170 | 24.41 | 4,149 |
| 2021-09-17 | RVMD | Sale | 166 | 30.02 | 4,983 |
| 2021-06-17 | RVMD | Sale | 160 | 34.12 | 5,459 |
| 2020-10-13 | RVMD | Sale | 10,000 | 44.00 | 440,000 |
| 2020-10-13 | RVMD | Option Ex | 10,000 | 2.68 | 26,800 |
| 2020-10-06 | RVMD | Option Ex | 10,000 | 2.68 | 26,800 |
| 2020-10-06 | RVMD | Sale | 10,000 | 40.00 | 400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anders Jack (Chief Financial Officer of Revolution Medicines, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.